Select a community
All Communities
Home > Community Treatment Reports > Cymbalta (duloxetine) Treatment Report
What is Cymbalta?

Cymbalta is the brand name for duloxetine, a selective serotonin & norepinephrine reuptake inhibitor (SSNRI), a type of anti-depressant reported to treat both emotional and physical symptoms of depression. Cymbalta is also prescribed for the treatment of diabetic peripheral neuropathic pain.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Depression 512 123
Fibromyalgia 350 111
Pain 163 37
Treat my mood condition(s) 142 29
Anxiety 73 24
Other 70 18

See all 1307 patients currently taking Cymbalta


Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
42 13%
Moderate
75 23%
Mild
91 27%
None
124 37%

Most commonly reported side effects

Sex drive (libido) decreased
83 25%
increased sweating
74 22%
Brain cloud
64 19%
Nausea
63 19%
Dizziness
60 18%
I feel flat
50 15%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Cymbalta. See all 32 dosages ►

  30mg as needed daily 1 mg daily 2 mg daily 60 mg weekly 10 mg daily 15 mg daily 20 mg daily 25 mg daily 180 mg weekly 30 mg daily 30 mg one time 33.125 mg daily 40 mg daily 45 mg daily 50 mg daily 60 mg daily 65 mg daily 75 mg daily 80 mg daily 90 mg daily 100 mg daily 120 mg daily 130 mg daily 150 mg daily 180 mg daily 200 mg daily 210 mg daily 240 mg daily 270 mg daily 1800 mg daily 5400 mg daily
  1 Number of Patients: 1 14 Number of Patients: 14 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 65 Number of Patients: 65 1 Number of Patients: 1 1 Number of Patients: 1 230 Number of Patients: 230 1 Number of Patients: 1 1 Number of Patients: 1 29 Number of Patients: 29 1 Number of Patients: 1 1 Number of Patients: 1 718 Number of Patients: 718 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 99 Number of Patients: 99 4 Number of Patients: 4 157 Number of Patients: 157 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Cymbalta (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
117 41% Side effects too severe: 41%
Did not seem to work
95 34% Did not seem to work: 34%
Doctor's advice
63 22% Doctor's advice: 22%
Other
46 16% Other: 16%
Expense
36 13% Expense: 13%
Personal research
10 4% Personal research: 4%
Course of treatment ended
4 1% Course of treatment ended: 1%
Not indicated
2 1% Not indicated: 1%

See all 267 patients who’ve stopped taking Cymbalta

Duration See details about how long patients take this treatment ▼

Currently Taking Cymbalta

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
17
72
108
205
180
249

Stopped Taking Cymbalta

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
48
73
44
38
30
34

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
278 84%
Usually
45 14%
Sometimes
3 1%
Never
6 2%

Burden

Difficulty being on treatment

Very
31 9%
Somewhat
39 12%
A little
59 18%
Not at all
203 61%

Cost

Paid out of pocket

$200+
4 1%
$100-199
22 7%
$50-99
33 10%
$25-49
90 27%
< $25
84 25%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.